Use of 3D Printing for Creation of Implantable Devices (R21/R33)
This Funding Opportunity Announcement (FOA) encourages applications for Phased Innovation (R21/R33) grant awards to utilize 3D printing technologies to develop implantable devices and biodegradable scaffolds for long-term use that will adapt to the needs of growing children. This FOA provides support for up to two years (R21 phase) for research planning activities and feasibility studies, followed by a possible transition to expanded research support (R33 phase). Transition to the R33 depends on the completion of applicant-defined milestones, as well as program priorities and the availability of funds.
General information about this opportunity
Last Known Status
Agency: Department of Health and Human Services
Office: National Institutes of Health
Type(s) of Assistance Offered
Number of Awards Available
Who is eligible to apply/benefit from this assistance?
See full announcement for complete details.
What is the process for applying and being award this assistance?
Other Assistance Considerations
Formula and Matching Requirements
This program does not have cost sharing or matching requirements.
Who do I contact about this opportunity?
eRA Service Desk
Monday to Friday 7 am to 8 pm ET